Ilvigrip (Phenylephrine Hydrochloride, Guaifenesin, Paracetamol)

Phenylephrine narrows blood vessels in the nasal passages, reducing swelling and congestion. Guaifenesin thins and loosens mucus, making it easier to cough up. Paracetamol acts on the central nervous system to lower fever and alleviate pain, providing comprehensive symptom control.

The appropriate dose of Ilvigrip is determined by a qualified healthcare professional based on the patient’s age, weight, medical condition and other medications. Patients should follow the prescriber’s instructions and the product label.

Safety of Ilvigrip in pregnancy or lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using the product to weigh potential benefits against risks.

To request Ilvigrip, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike single‑ingredient products, Ilvigrip offers a three‑component formulation that simultaneously addresses congestion, mucus clearance and pain/fever. This multi‑symptom approach can reduce the need for multiple separate medications, simplifying treatment compared with products that contain only a decongestant or only an analgesic.

Ilvigrip should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, direct sunlight and excessive heat to maintain potency throughout the shelf life.

Ilvigrip is taken orally with a full glass of water. The tablet should be swallowed whole and not chewed or crushed, unless a healthcare professional advises otherwise.

Serious risks include severe allergic reactions such as anaphylaxis, significant elevation of blood pressure, and rare liver injury. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, swelling, rash, sudden hypertension or jaundice.

Ilvigrip should be avoided by individuals with known hypersensitivity to any of its ingredients, those with uncontrolled hypertension, severe liver disease, or who are taking monoamine oxidase inhibitors. Children under the age recommended on the label should not use the product without medical guidance.